A citation-based method for searching scientific literature

C A Amritha, Punnagai Kumaravelu, D Darling Chellathai. J Clin Diagn Res 2015
Times Cited: 24







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.
Angelo Pietro Femia, Laura Raimondi, Giulia Maglieri, Maura Lodovici, Edoardo Mannucci, Giovanna Caderni. Int J Cancer 2013
41
37

NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.
Hui Wang, Xiufei Liu, Min Long, Yi Huang, Linlin Zhang, Rui Zhang, Yi Zheng, Xiaoyu Liao, Yuren Wang, Qian Liao,[...]. Sci Transl Med 2016
138
25

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
M Gokhale, J B Buse, C L Gray, V Pate, M A Marquis, T Stürmer. Diabetes Obes Metab 2014
52
25

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
549
20

Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
Jae-Hwi Jang, Lesley Baerts, Yannick Waumans, Ingrid De Meester, Yoshito Yamada, Perparim Limani, Ignacio Gil-Bazo, Walter Weder, Wolfgang Jungraithmayr. Clin Exp Metastasis 2015
42
20

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll, Matthew L Albert. Nat Immunol 2015
160
16

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
16





Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors.
Phyo T Htoo, John B Buse, Mugdha Gokhale, M Alison Marquis, Virginia Pate, Til Stürmer. Eur J Clin Pharmacol 2016
9
33

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
12

Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database.
Angela K Nagel, Nabila Ahmed-Sarwar, Paul M Werner, Gabriela C Cipriano, Robbert P Van Manen, Jack E Brown. Ann Pharmacother 2016
14
21

Functional expression of sodium-glucose transporters in cancer.
Claudio Scafoglio, Bruce A Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A Moatamed, Jiaoti Huang, Hermann Koepsell, Jorge R Barrio,[...]. Proc Natl Acad Sci U S A 2015
115
12

Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials.
Matteo Monami, Ilaria Dicembrini, Edoardo Mannucci. Acta Diabetol 2014
77
12

Sulphonylureas and cancer: a case-control study.
Matteo Monami, Caterina Lamanna, Daniela Balzi, Niccolò Marchionni, Edoardo Mannucci. Acta Diabetol 2009
134
12

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials.
Matteo Monami, Ilaria Dicembrini, Daniele Martelli, Edoardo Mannucci. Curr Med Res Opin 2011
155
12


Diabetes and cancer: a consensus report.
Edward Giovannucci, David M Harlan, Michael C Archer, Richard M Bergenstal, Susan M Gapstur, Laurel A Habel, Michael Pollak, Judith G Regensteiner, Douglas Yee. Diabetes Care 2010
12

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
12

Relationship between parenchymal involvement and obstructive sleep apnea in subjects with sarcoidosis.
Zuleyha Bingol, Aylin Pihtili, Ziya Gulbaran, Esen Kiyan. Clin Respir J 2015
35
12


DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
188
12

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
40
12

The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
Naoki Yorifuji, Takuya Inoue, Munetaka Iguchi, Kaori Fujiwara, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Ken Kawakami, Yosuke Abe, Toshihisa Takeuchi,[...]. Oncol Rep 2016
13
23

Dipeptidyl peptidase-4: a key player in chronic liver disease.
Minoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, Michio Sata. World J Gastroenterol 2013
112
12

Metformin and reduced risk of cancer in diabetic patients.
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris. BMJ 2005
8

Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.
Yuehong Chen, Liang Du, Ling Li, Jun Ma, Xingyuan Geng, Xun Yao, Guanjian Liu, Xin Sun. J Diabetes 2017
12
16


Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Simona Bo, Anna Castiglione, Ezio Ghigo, Luigi Gentile, Marilena Durazzo, Paolo Cavallo-Perin, Giovannino Ciccone. Eur J Endocrinol 2013
25
8

Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells.
Agnieszka Sliwinska, Aneta Rogalska, Marzena Szwed, Jacek Kasznicki, Zofia Jozwiak, Jozef Drzewoski. Mol Biol Rep 2012
31
8

Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis.
Cristina Bosetti, Valentina Rosato, Danilo Buniato, Antonella Zambon, Carlo La Vecchia, Giovanni Corrao. Oncologist 2013
95
8

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration.
Linda A Villani, Brennan K Smith, Katarina Marcinko, Rebecca J Ford, Lindsay A Broadfield, Alex E Green, Vanessa P Houde, Paola Muti, Theodoros Tsakiridis, Gregory R Steinberg. Mol Metab 2016
62
8

Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
Takashi Nomiyama, Takako Kawanami, Shinichiro Irie, Yuriko Hamaguchi, Yuichi Terawaki, Kunitaka Murase, Yoko Tsutsumi, Ryoko Nagaishi, Makito Tanabe, Hidetaka Morinaga,[...]. Diabetes 2014
56
8

DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells.
K Masur, F Schwartz, F Entschladen, B Niggemann, K S Zaenker. Regul Pept 2006
41
8


Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
Andrea Decensi, Matteo Puntoni, Pamela Goodwin, Massimiliano Cazzaniga, Alessandra Gennari, Bernardo Bonanni, Sara Gandini. Cancer Prev Res (Phila) 2010
608
8

Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.
Richard M Turner, Chun S Kwok, Chen Chen-Turner, Chinedu A Maduakor, Sonal Singh, Yoon K Loke. Br J Clin Pharmacol 2014
90
8

Chemotherapy and chemoprevention by thiazolidinediones.
Eleonore Fröhlich, Richard Wahl. Biomed Res Int 2015
49
8

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
L A Leiter, H Teoh, O Mosenzon, A Cahn, B Hirshberg, C A M Stahre, J B L Hoekstra, M Alvarsson, K Im, B M Scirica,[...]. Diabetes Obes Metab 2016
19
10


Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study.
Xinfeng Yan, Bo Feng, Peicheng Li, Zhaosheng Tang, Lin Wang. J Diabetes Res 2016
46
8

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.
Gorka Larrinaga, Itxaro Perez, Begoña Sanz, Maider Beitia, Peio Errarte, Ainhoa Fernández, Lorena Blanco, María C Etxezarraga, Javier Gil, José I López. PLoS One 2015
23
8

Cancer biology in diabetes.
Shi Sen, Yanzheng He, Daisuke Koya, Keizo Kanasaki. J Diabetes Investig 2014
20
10


Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.
A Mari, W M Sallas, Y L He, C Watson, M Ligueros-Saylan, B E Dunning, C F Deacon, J J Holst, J E Foley. J Clin Endocrinol Metab 2005
303
8



Exendin-4 does not modify growth or apoptosis of human colon cancer cells.
He Wenjing, Yu Shuang, Li Weisong, Xiao Haipeng. Endocr Res 2017
6
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.